These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
594 related articles for article (PubMed ID: 26268531)
1. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531 [TBL] [Abstract][Full Text] [Related]
2. Panencephalopathic Creutzfeldt-Jakob disease with distinct pattern of prion protein deposition in a patient with D178N mutation and homozygosity for valine at codon 129 of the prion protein Gene. Marcon G; Indaco A; Di Fede G; Suardi S; Finato N; Moretti V; Micoli S; Fociani P; Zerbi P; Pincherle A; Redaelli V; Tagliavini F; Giaccone G Brain Pathol; 2014 Mar; 24(2):148-51. PubMed ID: 24118545 [TBL] [Abstract][Full Text] [Related]
3. Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes. Diack AB; Boyle A; Plinston C; Hunt E; Bishop MT; Will RG; Manson JC Brain; 2019 May; 142(5):1416-1428. PubMed ID: 30938429 [TBL] [Abstract][Full Text] [Related]
4. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease. Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604 [TBL] [Abstract][Full Text] [Related]
5. Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman. Mead S; Joiner S; Desbruslais M; Beck JA; O'Donoghue M; Lantos P; Wadsworth JD; Collinge J Arch Neurol; 2007 Dec; 64(12):1780-4. PubMed ID: 18071044 [TBL] [Abstract][Full Text] [Related]
6. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type. Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639 [TBL] [Abstract][Full Text] [Related]
7. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2. Samman I; Schulz-Schaeffer WJ; Wöhrle JC; Sommer A; Kretzschmar HA; Hennerici M J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):678-81. PubMed ID: 10519881 [TBL] [Abstract][Full Text] [Related]
8. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
9. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology? Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817 [TBL] [Abstract][Full Text] [Related]
10. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776 [TBL] [Abstract][Full Text] [Related]
12. An autopsied case of Creutzfeldt-Jakob disease with mutation in the prion protein gene codon 232 and type 1+2 prion protein. Iwasaki Y; Yokoi F; Tatsumi S; Mimuro M; Iwai K; Kitamoto T; Yoshida M Neuropathology; 2013 Oct; 33(5):568-75. PubMed ID: 23320809 [TBL] [Abstract][Full Text] [Related]
13. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Cervenáková L; Goldfarb LG; Garruto R; Lee HS; Gajdusek DC; Brown P Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13239-41. PubMed ID: 9789072 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649 [TBL] [Abstract][Full Text] [Related]
15. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology. Duyckaerts C; Sazdovitch V; Ando K; Seilhean D; Privat N; Yilmaz Z; Peckeu L; Amar E; Comoy E; Maceski A; Lehmann S; Brion JP; Brandel JP; Haïk S Acta Neuropathol; 2018 Feb; 135(2):201-212. PubMed ID: 29209767 [TBL] [Abstract][Full Text] [Related]
16. An autopsy case of MV2K-type sporadic Creutzfeldt-Jakob disease presenting with characteristic clinical, radiological, and neuropathological findings. Matsuo K; Goto D; Hasegawa M; Ogita K; Koyama T; Akagi A; Kitamoto T; Yoshida M; Iwasaki Y Neuropathology; 2022 Jun; 42(3):245-253. PubMed ID: 35441383 [TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene. Komatsu J; Sakai K; Hamaguchi T; Sugiyama Y; Iwasa K; Yamada M Prion; 2014; 8(5):336-8. PubMed ID: 25495585 [TBL] [Abstract][Full Text] [Related]
18. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Mitrová E; Belay G Acta Virol; 2002; 46(1):31-9. PubMed ID: 12197632 [TBL] [Abstract][Full Text] [Related]